October 2021
Issue 2
Letter From the JCTS Editor: Timely Themes
October is not only a time of transition but also a time to enjoy the fall foliage as the last days of summer passes by. This year, we can also enjoy the return of students to our campuses and there are many happy smiles wherever one goes. We can only hope that the situation continues to normalize and that we all can focus on the work and studies at hand. JCTS continues to thrive and I am happy to announce the completion of yet another thematic issue which will be posted on our website any day. The Team Science thematic issue contains 13 publications and is anchored by an introductory editorial authored by the group organizing the effort. I am very grateful to Betsy Rolland, Jennifer Cross, Sarah Hohl, LaKaija Johnson, Kevin Wooten and Allan Brasier who were instrumental in the planning and orchestration of the issue. I warmly recommend our readers to look at these papers which collectively address many key aspects of successfully undertaking team science. The scope is central to clinical and translational science and there are many valuable portable concepts.
I mentioned last month the current call for a thematic issue on Health and Social Drivers in the Criminal Justice System. This area is of paramount societal importance and was highlighted in the current issue of Science that devoted a section to mass incarceration. Among areas highlighted in the Science reviews were the importance of structural racism for criminal justice and its predatory dimensions. We very much look forward to contributions to the JCTS thematic issue and the call is open for submissions until March 1, 2022. We have also just launched another call for thematic contributions in the area of Diversity, Equity and Inclusion in Clinical and Translational Science. The effort is led by Ebony Boulware, Giselle Corbie-Smith, Sergio Aguilar-Gaxiola, Consuelo Wilkins and Leonard Egede and the deadline for that call is April 30, 2022. This is another timely area and we hope the call will attract a number of submissions.
In addition to the two thematic areas that are open for submissions, we encourage our readers to consider other areas where there may be interest to highlight a theme. In general, the process has worked very well when a number of colleagues interested in an area come together with a proposal to JCTS. I feel there are several areas worthy of consideration and look forward to discussions to identify such areas of common interest. Of course, beyond thematic areas, JCTS is always open for contributions relevant to clinical and translational science and our editorial board and our many highly qualified reviewers are committed to a timely process of submitted manuscripts. Again, I want to thank everyone who has submitted papers to JCTS, our hardworking and efficient Editorial Board, the great staff at ACTS and JCTS, our publisher Cambridge University Press and our partners at the Clinical Research Forum for a great year so far. Stay safe!
Lars Berglund, M.D., Ph.D., FAHA
Editor-in-Chief, Journal of Clinical and Translational Science (JCTS)
Translational Science 2022: Last Chance for Session Proposals!
Time is running out to submit scientific session proposals for Translational Science: Transformational Translational Science: Opportunities for Success! Don't miss your chance to make a big impact on clinical and translational research.
Scientific session proposals are due Monday, November 1. Please visit our website to learn more about the submission portal, best practices, and more.
Poster proposals are due Monday, November 29. We look forward to receiving your scientific session ideas and posters submissions!
News From the Hill: October 23, 2021
The Chairman of the Senate Appropriations Committee, Patrick Leahy (D-VT) recently released the nine outstanding Senate Fiscal Year (FY) 2022 spending bills. The nine posted bills included the Labor-HHS-Education funding measure and the funding measure for the Department of Defense. These bills have not gone through the official markup process but were released to indicate Senate (largely Democratic) priorities and to facilitate timely negotiations with the House on final FY 2022 spending bills. The FY 2022 appropriations bills will ultimately need the support of both parties and both chambers (Republicans are already suggesting enhancements to defense spending), and negotiations are expected to stretch into December.
Read more on the ACTS Advocacy page.
August M. Watanabe Prize in Translational Research
Indiana University School of Medicine is pleased to award the August M. Watanabe Prize in Translational Research. The prize is one of the nation’s largest and most prestigious awards, recognizing individuals focused on shepherding scientific discoveries into new therapies for patients. The prize is awarded to a senior investigator who has made a significant contribution to the field of translational science. The winner will receive $100,000 and will spend September 14-16, 2022 in Indianapolis, as a vising dignitary, sharing insights and knowledge with audiences at IU School of Medicine and its partner institutions.
Nominees for the August M. Watanabe Prize in Translational Research should be members of the scientific or medical community who have demonstrated outstanding accomplishments in translational research.
The deadline for all nomination materials for the award is January 21, 2022. Any questions about the nomination process may be directed to amwprize@iu.edu or 317-278-2874.
Career Center
The ACTS Career Center is the premier resource for connecting those in the field of translational science with career opportunities. Visit today to find a wealth of resources to help achieve your career goals.
ACTS members receive a 50% discount on the site—use code ACTSMEMBER to save!
Special Interest Groups
ACTS offers its members the opportunity to participate in Special Interest Groups (SIGs) related to the field of clinical research and translational science. SIGs connect individuals who share similar goals and interests, providing a channel to network and participate in knowledge and resource sharing among peers.
Translational Science Today
Remote trials topic of workshop
Research News By CHRISTOPHER SCHOBERT One of the many impacts of the COVID-19 pandemic on clinical and translational research was the sudden and necessary increase in remote trials. This complex shift, what it means for investigators and...
Read more
www.buffalo.edu